Media Room Menu
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 7, 2019* Only biologic approved in the EU for severe asthma with type 2 inflammation, as characterized by raised blood eosinophils and/or raised fractional exhaled nitric oxide (FeNO)
-
Apr 26, 2019* Praluent is the first PCSK9 inhibitor that has shown a meaningful reduction in death from any cause
-
Apr 24, 2019- Top-line Data Anticipated in the Fourth Quarter of 2019 -
Apr 10, 2019* Sanofi continues its commitment to helping reduce cost burden for people living with diabetes with first-ever insulin savings program-
Apr 9, 2019Pivotal Study to Evaluate Potential of Anti-CD3 Monoclonal Antibody to Intercept Type 1 Diabetes
-
Apr 2, 2019Strengthens Leadership Team with Appointment of Douglas Jacobstein, M.D. as V.P. of Clinical Development and Alex Rabiee as V.P. of Business Development
-
Mar 28, 2019Dr. Bluestone is a World-renowned Expert and Academic Leader in Immune Tolerance Research
